Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) Equity Average (2020 - 2025)

Stemtech's Equity Average history spans 6 years, with the latest figure at -$6.1 million for Q3 2025.

  • For Q3 2025, Equity Average changed N/A year-over-year to -$6.1 million; the TTM value through Sep 2025 reached -$6.1 million, changed N/A, while the annual FY2024 figure was -$3.6 million, 22.05% down from the prior year.
  • Equity Average for Q3 2025 was -$6.1 million at Stemtech, down from -$6.1 million in the prior quarter.
  • Across five years, Equity Average topped out at $1.1 million in Q1 2021 and bottomed at -$16.7 million in Q3 2022.
  • The 5-year median for Equity Average is -$4.2 million (2023), against an average of -$5.0 million.
  • The largest annual shift saw Equity Average crashed 5250.53% in 2022 before it surged 83.91% in 2023.
  • A 5-year view of Equity Average shows it stood at -$4.2 million in 2021, then increased by 6.52% to -$3.9 million in 2022, then skyrocketed by 43.26% to -$2.2 million in 2023, then crashed by 109.44% to -$4.7 million in 2024, then tumbled by 30.7% to -$6.1 million in 2025.
  • Per Business Quant, the three most recent readings for STEK's Equity Average are -$6.1 million (Q3 2025), -$6.1 million (Q2 2025), and -$5.1 million (Q1 2025).